Related Experiment Video
Updated: Nov 24, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Therapy Discontinuation after Myocardial Infarction
Łukasz Pietrzykowski1, Michał Kasprzak2, Piotr Michalski1
1Department of Health Promotion, Collegium Medicum, Nicolaus Copernicus University, M. Curie Skłodowskiej 9 St., 85-094 Bydgoszcz, Poland.
Insights
Most heart attack patients stop taking essential medications within a year, increasing risks. Older age and prior revascularization predict discontinuation, with statins most commonly stopped.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Discontinuation of recommended pharmacotherapy after myocardial infarction (MI) increases the risk of thrombotic complications.
- Understanding nonadherence patterns is crucial for improving patient outcomes post-MI.
Purpose of the Study:
- To comprehensively analyze short- and long-term pharmacotherapy discontinuation in post-MI patients.
- To identify determinants of medication nonadherence within one year of MI.
Main Methods:
- A single-center cohort clinical trial with 225 post-MI patients and one-year follow-up.
- Analysis of therapy initiation, short-term (<30 days), long-term (≥30 days), and permanent discontinuation using prescription filling data.
Main Results:
- Occupational activity and prior MI predicted lack of P2Y12 inhibitor initiation.
- Older age (>65 years) and prior revascularization predicted overall therapy discontinuation.
- No independent predictors for simultaneous cessation of all medications were identified.
Conclusions:
- A majority of post-MI patients discontinue at least one essential medication within a year.
- Statins are the most frequently discontinued medication class.
- Older age and prior cardiac revascularization are key determinants of medication discontinuation.
Abstract:
The discontinuation of recommended therapy after myocardial infarction predisposes patients to serious thrombotic complications. The aim of this study was a comprehensive analysis of permanent as well as short- and long-term discontinuation of pharmacotherapy, taking into consideration the basic groups of medications and nonadherence determinants in a one-year follow-up in post-myocardial infarction (MI) patients.
Material And Methods:
The study was a single center cohort clinical trial with a one-year follow-up including 225 patients (73.3% men, 26.7% women) aged 62.9 ± 11.9 years. In eight cases (3.6%), the follow-up duration was less than one year due to premature death. The following factors were analyzed: lack of post-discharge therapy initiation; short-term therapy discontinuation (<30 days); long-term therapy discontinuation (≥30 days); and permanent cessation of therapy. The analysis of therapy discontinuation was performed based on prescription filling data.
Results:
Occupational activity (Odds Ratio (OR) 5.15; 95% Confidence interval (CI) 1.42-18.65; p = 0.013) and prior MI (OR 5.02; 95% CI 1.45-16.89; p = 0.009) were found to be independent predictors of a lack of post-discharge therapy initiation with P2Y12 receptor inhibitors. We found no independent predictors of lack of post-discharge therapy initiation with other medications, whether analyzed separately or together. Age above 65 years (Hazard Ratio (HR)-1.59; 95% CI 1.15-2.19; p = 0.0049) and prior revascularization (HR-1.44; 95% CI 1.04-2.19; p = 0.0273) were identified as independent predictors of therapy discontinuation. Multilogistic regression analysis showed no independent predictors of the cessation of any of the medications as well as the permanent or temporary simultaneous discontinuation of all medications.
Conclusions:
The vast majority of post-MI patients discontinue, either temporarily or permanently, one of the essential medications within one year following myocardial infarction. The most likely medication class to be discontinued are statins. Older age and prior cardiac revascularization are independent determinants of therapy discontinuation.
Related Concept Videos
Myocarditis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Acute Coronary Syndrome I: Introduction

